Pharmaceutical Executive-11-01-2019

Pharmaceutical Executive
Features

December 05, 2019

Pharrm Exec's 2020 Pipeline Report

Pharmaceutical Executive

Pharm Exec chronicles the journey of gene therapy visionary R. Jude Samulski, whose work unraveling the mysteries of adeno-associated virus continues to fuel new hopes in transforming drugs for rare disease.

Pharmaceutical Executive
From the Editor

November 09, 2019

Though uncertain market dynamics remain at play, the current magnitude of innovation in biopharma is staggering, and, at times, overwhelming.

Pharmaceutical Executive

Measure would cut drug costs, slash revenues, curb R&D.

A formal effort is underway in Europe to gather concrete clues on the value of real-world evidence in payer decision-making.

Pharmaceutical Executive

Technology grabbing the attention of watchful industry

Pharmaceutical Executive

With pursuits of complex therapies more routine, biotech platform companies are tasked with aligning their science with process and manufacturing proficiency to stand out in an increasingly crowded investment field.

Issue PDF
Pharmaceutical Executive

November 01, 2019

Click the title above to open the Pharmaceutical Executive November 2019 issue in an interactive PDF format.

Special Sponsored Section
Pharmaceutical Executive

November 01, 2019

Boasting a long and proud tradition in the life sciences, consistently ranked among the world’s most pioneering countries, Sweden’s biggest task will be to maintain such standards in an era where medical science is becoming ever more sophisticated and integrated with other disciplines.